Non-invasive in vivo determination of viable islet graft volume by 111In-exendin-3
Abstract Pancreatic islet transplantation is a promising therapy for patients with type 1 diabetes. However, the duration of long-term graft survival is limited due to inflammatory as well as non-inflammatory processes and routine clinical tests are not suitable to monitor islet survival. 111In-exen...
Saved in:
Main Authors: | Wael A. Eter, Inge Van der Kroon, Karolina Andralojc, Mijke Buitinga, Stefanie M. A. Willekens, Cathelijne Frielink, Desiree Bos, Lieke Joosten, Otto C. Boerman, Maarten Brom, Martin Gotthardt |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/54496705e6054b69a78f30ff906bdda1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan
by: Lieke Joosten, et al.
Published: (2017) -
Pancreatic islet macroencapsulation using microwell porous membranes
by: Katarzyna Skrzypek, et al.
Published: (2017) -
Photodynamic Therapy Targeting Macrophages Using IRDye700DX-Liposomes Decreases Experimental Arthritis Development
by: Daphne N. Dorst, et al.
Published: (2021) -
Acta No. 111
by: Banco Central de Chile
Published: (2019) -
Exendin-4 Exhibits Enhanced Anti-tumor Effects in Diabetic Mice
by: Lan He, et al.
Published: (2017)